Abstract
The greatest impediment to long-term survival for adult and pediatric heart transplant recipients is the development of an accelerated form of coronary artery disease[1]–[4]. This is variously termed chronic allograft vasculopathy, chronic allograft coronary artery disease, or chronic rejection. This disease was reported in the original preclinical animal experiments, and subsequently in the early human heart transplant recipients at Stanford, USA 6.7 and Cape Town, South Africa”. The incidence of this disease has been estimated at 10% per year post-transplant[4],[9]’[11]. Although cyclosporin has been associated with an improvement in 1- and 5-year graft survival, as well as a decrease in death due to rejection, it has not had an impact on reducing the incidence of allograft coronary artery disease (ACAD)[12]’[15] in adults, but increased immunosuppression may decrease the incidence in pediatric patients[15].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walley V, Masters R, Boone S et al. Analysis of deaths after heart transplantation: the University of Ottawa Heart Institute experience. J Heart Lung Transplant. 1993; 12:790–81.
Carrier M, Pelletier G, Leclerc Y et al. Accelerated coronary atherosclerosis after cardiac transplantation: major threat to long-term survival. Can J Surg. 1991;34:133–6.
Pahl E, Fricker F, Armitage J et al. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990;116:177–83.
Schroeder J, Gao S, Hunt S et al. Accelerated graft coronary artery disease: diagnosis and prevention. J Heart Lung Transplant. 1992;11:S258–66.
Kosek J, Hurley E, Lower R. Histopathology of orthotopic canine cardiac homografts. Lab Invest. 1968;19:97–111.
Kosek JC, Hurley EJ, Lower RR. Heart graft arteriosclerosis. Transplant Proc. 1971;3:512–14.
Bieber CP, Stinson EB, Shumway NE et al. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation. 1970;41:753–72.
Thomson JG. Production of severe atheroma in a transplanted human heart. Lancet. 1969;2(630):1088–91.
Pennock J, Over P, Reitz B et al. Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg. 1982;83:168–77.
Pascoe E, Barnhart G, Carter W et al. The prevalence of cardiac allograft arteriosclerosis. Transplantation. 1987;44:838.
Young J. Cardiac allograft arteriopathy: an ischemic burden of a different sort. Am J Cardiol. 1992;70:9F–13F.
Uretsky B, Murali S, Reddy P et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporin and prednisone. Circulation. 1987;76:827–34.
Gao S, Schroeder J, Alderman E et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporin and azathioprine regimens. Circulation. 1989;89(Suppl. III):III–100.
Olivari M, Homans D, Wilson R et al. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation. 1989;80:III–111.
Addonizio L, Hsu D, Douglas J et al. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Circulation. 1993;88:224–9.
Gao S, Hunt S, Schroeder J et al. Does rapidity of development of transplant coronary artery disease portend a worse prognosis? J Heart Lung Transplant. 1994;13:1119–24.
Keogh A, Valuntine H, Hunt S et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992:11:892–901.
Park J, Hsu D, Hordof A et al. Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection. J Heart Lung Transplant. 1993;12:956–64.
Gao S, Schroeder J, Hunt S et al. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol. 1989;64:1093–7.
Wilson R, Christenson B, Olivari M et al. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation. 1991;83:1210–20.
Wharton J, Polak J, Gordon L et al. Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res. 1990;66:900–12.
Stark R, McGinn A, Wilson R. Chest pain in cardiac transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med. 1991;324:1791–807.
Miller L. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis. 1991;33:242–8.
Cramer D. Transplant arteriosclerosis. Transplant Sci. 1991;1:60–3.
Fyfe A. Transplant atherosclerosis: the clinical syndrome, pathogenesis, and possible model of spontaneous atherosclerosis. Can J Cardiol. 1992;8:509–19.
Barnhart G, Pascoe E, Mills A et al. Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev. 1987;1:31–46.
Ewel C, Foegh M. Chronic graft rejection: accelerated transplant arteriosclerosis. Immunol Rev. 1993;134:21–31.
Hosenpud J, Shipley G, Wagner C. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant. 1992;11:9–23.
Hosenpud J. Immune mechanisms of cardiac allograft vasculopathy: an update. Transplant Immunol. 1993;1:237–49.
Lurie KG, Billingham ME, Jamieson SW et al. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation. 1981;31:41–7.
Minick CR, Alonso DR, Rankin L. Role of immunologic arterial injury in at herogenesis. Thromb Haemost. 1978;29:304–11.
Cramer D, Chapman F, Wu G et al. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation. 1990;50:554–8.
Cramer D, Qian S. Harnaha J et al. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation. 1989;47:414–19.
Hosenpud J, Everett J, Morris T et al. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy. J Heart Lung Transplant (In press).
Libby P, Salomon R, Payne D et al. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc. 1989;21:3677–84.
Gravanis M. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis. Mod. Pathol. 1989;2:495–505.
Rose M, Dunn M. What causes accelerated coronary artery disease after cardiac transplantation? Primary Cardiol. 1993;19:34–9.
Almond P, Matas A, Gillingham K et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 1993;55:752–7.
Basadonna G, Malas A, Gillingham K et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation. 1993;55:993–5.
Heeman U, Azuma H, Tullius S et al. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation. 1994;58:1317–22.
Stovin P, Sharples L, Schofield P et al. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease. J Heart Lung Transplant. 1993;12:110–16.
Costanzo-Nordin M. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992;11:S90–103.
Zerbe T, Uretsky B, Kormos R et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992;11:S104–10.
Gao S, Schroeder J, Hunt S et al. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993;12:1029–35.
Schutz A, Kemkes R, Kugler C et al. The influence of rejection episodes on the development of coronary artery disease after heart transplantation. Eur J Cardiothorac Surg. 1990;4:300–8.
Winters GL, Loh E, Schoen FJ. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation. 1995;91:1975–80.
Fishbein M, Bell G, Lones M et al. Grade 2 cellular heart rejection: does it exist? J Heart Lung Transplant. 1994; 13:1051–7.
Yeoh T, Frist W, Eastbum T et al. Clinical significance of mild rejection of the cardiac allograft. Circulation. 1992;86:II–267–71.
Kobashigawa JA. Does acute rejection correlate with the development of transplant coronary artery disease? A multi-center study using intravascular ultrasound. Presented to the International Society for Heart and Lung Transplantation meeting, 1995. (In press).
Hammond E, Ensley R, Yowell R et al. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc. 1991;23:26–30.
Hess M, Hastillo A, Mohanakumar T et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B cell antibodies and hyperlipidemia. Circulation. 1983;68:II–94.
Rose E, Pepino P, Barr M et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant. 1992;11:S120–3.
Rose E, Smith C, Petrossian G et al. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery. 1989:106:203–8.
Fenoglio J, Ho E, Reed E et al. Anti-HLA antibodies and heart allograft survival. Transplant Proc. 1989;21;807–9.
Petrossian G, Nichols A, Marboe C et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation. 1989:80:III–122.
Rose M. Antibody-mediated rejection following cardiac transplantation. Transplant Rev. 1993;7:140–52.
Dunn M, Crisp S, Rose M et al. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 1992;339:1566–70.
Crisp S, Dunn M, Rose M et al. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant. 1994;13:81–92.
Wheeler C, Collins A, Dunn M et al. Characterization of endothelial antigens associated with transplant associated coronary artery disease. J Heart Lung Transplant. (In press).
Stinson EB, Payne R, Griepp RB et al. Correlation of histocompatibility matching with graft rejection and survival after cardiac transplantation in man. Lancet 1971;2(722):459–61.
Frist W, Oyer P, Baldwin J et al. HLA compatibility and cardiac transplant recipient survival. Ann Thorac Surg. 1987;44:242–6.
Smith J, Pomerance A, Burke M et al. Effect of HLA matching on graft function and long term survival after cardiac transplantation. Results of a large single center study. J Heart Lung Transplant. 1995;14:S40.
Costanzo MR. The role of histoincompatibility in cardiac allograft vasculopathy. J Heart Lung Transplant. (In press).
Costanzo-Nordin M. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant 1992;11:S90–103.
Cocanougher B, Ballantyne C, Pollack M et al. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc. 1993;25:233–6.
Johnson M. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant. 1992;11:S124–32.
Gao S, Hunt S, Alderman E et al. Relationship of donor age and preexisting coronary disease by angiography and intracoronary ultrasound to later development of cardiac allograft coronary artery disease. J Heart Lung Transplant. 1995;14:S40.
Schuler S, Matschke K, Loebe M et al. Coronary artery disease in patients with hearts from older donors: morphologic features and therapeutic implications. J Heart Lung Transplant. 1993;12:100–9.
Winters GL, Kendall TJ, Radio SJ et al. Posttransplant obesity and hyperlipidemia: major predictors of seventy of coronary arteriopathy in failed human heart allografts. J Heart Transplant. 1990;9:364–71.
Gao S, Schroeder J. Alderman E et al. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation. 1987;76:V–56–61.
Valantine H. Role of lipids in allograft vascular disease: a multi-center study of intimal thickening detected by intravascular ultrasound. J Heart Lung Transplant. 1996;14:5234–7.
Alonso DR, Starek PK, Minick CR. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 1977;87:415–42.
Mennander A, Tikkanen M, Raisanen-Sokolowski A et al. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis. J Heart Lung Transplant. 1993;12:123–32.
Hajjar D, Fabricant C, Minick C et al. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol. 1986;122:62–70.
Virella G, Lopes-Virella M. Infections and atherosclerosis. Transplant Proc. 1987;19:26–35.
Melnick J, Debakey M. Cytomegalovirus and atherosclerosis. Eur Heart J. 1993;14:30–8.
Kendall T, Wilson J, Radio S et al. Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant. 1992;11:S14–20.
Grattan M, Moreno-Cabral C, Starnes V et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc. 1989;261:3561–6.
Fay L. Cytomegalovirus and coronary artery disease in heart transplant patients-accelerated low density lipoprotein and lipoprotein(A) modification as a proposed factor. J Heart Lung Transplant. 1994;12:155.
Koskinen P, Nieminen M, Krogerus L et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant. 1993;12:724–9.
Everett J, Hershberger R, Norman D et al. Prolonged cytomegalovirus infection is associated with development of acute cardiac allograft vasculopathy. J Heart Lung Transplant. 1992;11:S133–7.
McDonald K, Rector T, Braunlin E et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol. 1989;64:359–62.
Hendry PJ, Walley VM, Koshal A et al. Are temperatures attained by donor hearts during transport too cold? J Thorac Cardiovasc Surg. 1989;98:517–22.
Gaudin P, Rayburn B, Hutchins G et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol. 1994;18:338–46.
Day J, Hutchins G, Byrne B et al. Accelerated arteriosclerosis in heart transplant recipients: the central pathogenetic role of endothelial cell injury. J Heart Lung Transplant. (In press).
Land W, Schneeberger H, Schleibner S et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 1994;57:211–17.
Miller L. Allograft vascular disease: a disease not limited to hearts. J Heart Lung Transplant. 1992;11:S32–7.
Ip J, Fuster V, Badimon L et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667–87.
Dzau V. Gibbons G, Cooke J et al. Vascular biology and medicine in the 1990s: scope, concepts, potentials and perspectives. Circulation. 1993;87:705–19.
Gibbons G, Dzau V. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431–8.
Vane J. Anggard F, Botting R. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27–36.
Gibbons G. The pathogenesis of graft vascular disease: implications of vascular remodeling. J Heart Lung Transplant. 1996;14:5149–57.
Libby P, Schwartz D. Brogi E et al. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1993;86:III–47–52.
Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation. 1992;86:723–9.
Heistad D, Armstrong M. Sick vessel syndrome. Can atherosclerotic arteries recover? Circulation. 1994;89:2447–50.
Billingham M. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11:S38–44.
Johnson D, Gao S, Schroeder J et al. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Lung Transplant. 1989;8:349–59.
Billingham M. Graft coronary disease: the lesions and the patients. Transplant Proc. 1989;21:3665–6.
Libby P. Inflammatory and immune mechanisms in atherogenesis. Atherosclerosis Rev. 1990;21:79–89.
Salomon R, Hughes C, Schoen F et al. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 1991;138:791–8.
Gordon D. Growth factors and cell proliferation in human transplant arteriosclerosis. J Heart Lung Transplant. 1992;11:S7.
Allen M, McDonald T, Carlos T et al. Endothelial adhesion molecules in heart transplantation. J Heart Lung Transplant. 1992;11:S8–13.
Hayry P. Mennander A, Raisanen SA et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev. 1993;7:1–20.
Clowes A. Regulation of intimal hyperplasia through control of matrix proteolysis. Restenosis Summit V, 1993: Cleveland Clinic. 122–3.
Zeiher A, Schachinger V, Hohnloser S et al. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 1994;89:2525–32.
Libby P, Hansson G. Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5–15.1
Foegh ML, Khirabadi BS, Chambers E et al. Peptide inhibition of accelerated transplant atherosclerosis. Transplant Proc. 1989;21:3674–6.
Foegh M, Khirabadi B, Chambers E et al. Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Atherosclerosis. 1989;78:229–36.
Clowes A. Control of intimal hyperplasia by heparin. J Heart Lung Transplant. 1992:11:S21.
Faulk W, Labarrere C, Nelson D et al. Alterations in hemostasis, fibrinolysis and natural anticoagulation in transplant vascular sclerosis. J Heart Lung Transplant. 1996;14:5158–64.
Small F, Ballantyne C, Cocanougher B et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 1991;67:243–7.
Rodney R, Johnson L. Myocardial perfusion scintigraphy to assess heart transplant vasculopathy. J Heart Lung Transplant. 1992:11:S74–78.
McKillop J, Goris M. Thallium 201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol. 1981;32:447–9.
Rodney R, Johnson L, Blood D et al. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi. J Heart Lung Transplant. 1994;13:173–89.
Mazeika P, Nadazdin A, Oakley C. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol. 1992;19:1203–11.
Herregods M, Anastassiuo I, Van Cleemput J et al. Dobutamine stress echo cardiography after heart transplantation. J Heart Lung Transplant. 1994;13:1039–44.
Akosah K, Mohanty P, Funai J et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant. 1994;13:1024–38.
Young J, Windsor N, Kleiman N et al. The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation. J Heart Lung Transplant. 1992;11:S79–82.
Rechavia E, Araujo L, DeSilva R et al. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15 labeled water and positron emission tomography. J Am Coll Cardiol. 1992:19:100–6.
Gao S, Alderman E, Schroeder J et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334–40.
Bajaj S, Shah A, Crandall C et al. Coronary collateral circulation in the transplanted heart. Circulation. 1993;88:263–9.
O’Neill B, Pflugfelder P, Singh N et al. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. J Am Cardiol. 1989;63:1221–6.
Petrossian G, Nichols A, Rose E et al. Quantitative cinevideodensitometric analysis of serial coronary angiograms following cardiac transplantation. J Invas Cardiol. 1993;5:258–66.
deFeyter P, Serruys P, Davies M et al. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Circulation. 1991;84:412–23.
Mills R, Hills J, Theron H et al. Serial quantitative coronary angiography in the assessment of coronary disease in the transplanted heart. J Heart Luny Transplant. 1992;11:S52–5.
Everett J, Hershberger R, Ratkovec R et al. The specificity of normal qualitative angiography in excluding cardiac allograft vasculopathy. J Heart Lung Transplant. 1994;13:142–9.
Uretsky B. Kormos R, Zerbe T et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant. 1992;11:LS45–51.
Alderman F. Angiographic implications of cardiac transplantation. Am J Cardiol. 1989;64:16F–21E.
Nitkin R, Hunt S, Schroeder J. Accelerated atherosclerosis in a cardiac transplant patient. J Am Coll Cardiol. 1985;6:243–5.
Dressler F, Miller L. Necropsy versus angiography: how accurate is angiography? J Heart Lung Transplant. 1992;3:S56–9.
Glagov S, Weisenberg E, Zarins C et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5.
Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation. 1994;89:2888–91.
Steinke W, Hennerici M. Compensatory carotid artery dilatation in early atherosclerosis. Circulation. 1994;89:2578–81.
Losordo D, Rosenfield K, Kaufman J et al. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation. 1994;89:2570–7.
Post M, Borst C, Kuntz R. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816–21.
Kakuta T. Currier J, Haudenschild C et al. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypereholesterolemic rabbit model. Circulation. 1994,89:2809–15.
Gao S, Alderman E, Schroeder J et al. Progressive coronary luminal narrowing after cardiac transplantation. Circulation. 1990;82:IV–269–75.
Young J, Smart F, Lowry R et al. Coronary angiography after heart transplantation: should perioperative study be the ‘gold standard’? J Heart Lung Transplant. 1992;11:S65–8.
Boffa G, Faggian G, Buja G et al. Coronary artery spasm in heart transplant recipients. J Heart Transplant. 1989;8:154–8.
Palmer D, Tsai C, Roodman S et al. Heart graft arteriosclerosis. An ominous finding on endomyocardial biopsy. Transplantation. 1985;39:385–8.
Mason J, Strefling A. Small vessel disease of the heart resulting in myocardial necrosis and death despite angiographically normal coronary arteries. Am J Cardiol. 1979;44:171–6.
Neish A, Loh E, Schoen F. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis. J Am Coll Cardiol. 1992;19:586–92.
Sharpies L, Mullins P, Cary N et al. A method of analyzing the onset and progression of coronary occlusive disease after transplantation and its effect on patient survival. J Heart Lung Transplant. 1993;12:381–7.
Balk A, Simoons M, Linden M et al. Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant. 1993;12:89–99.
Miller L, Wolford T, Donohue T et al. Cardiac allograft vasculopathy: new insights from intravascular ultrasound and coronary flow measurements. Transplant Rev. 1995;9:77–96.
Miller L. The role of intracoronary ultrasound for the diagnosis of cardiac allograft vasculopathy. Transplant Proc. 1995;27(31):1989–92.
Pinto F, St. Goard F, Gao SZ et al. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography. Circulation. 1993;88:1709–14.
The Safety of ICUS Study Group. Safety of intracoronary ultrasound: a multicenter, multicathetcr registry in 1837 patients. Circulation. 1993;88:I–549.
Pinto F, Chenzbraun A, Botas J et al. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation. 1994;90:2348–55.
Pflugfelder P, Boughner D, Rudas L et al. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging. Am Heart J. 1993; 125:1583–91.
St Goar F, Pinto F, Alderman E et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation. 1992;86:756–63.
St Goar F, Pinto F, Alderman E et al. Intracoronary ultrasound in cardiac transplant recipients. In-vivo evidence of ‘angiographically silent’ intimal thickening. Circulation. 1992;85:979–87.
Fitzgerald P, St Goar F, Connolly A et al. Intravascular ultrasound imaging of coronary arteries. Is three layers the norm? Circulation. 1992;86:154–8.
Roelandt J, diMario C, Pandian N et al. Three-dimensional reconstruction of intracoronary ultrasound images. Rationale, approaches, problems, and directions. Circulation. 1994;90:1044–55.
Tuzcu E, DeFranco A, Hobbs R et al. Prevalence and distribution of transplant coronary artery disease: insights from intravascular ultrasound imaging. J Heart Lung Transplant. 1995;14:5202–6.
Nissen SE, Tuzcu M, DeFranco AC et al. Predominances of coronary disease in proximal segments with sparing of distal sites: evidence from intravascular ultrasound. J Heart Lung Transplant. 1994;13:S59.
Nerem R, Harrison D. Taylor W et al. Hemodynamics and vascular endothelial biology. J Cardiovasc Pharmacol. 1993;21:S6–10.
Botas J, Pinto FJ, Chenzbraun A et al. Progression of intimal thickening after cardiac transplantation: is it influenced by preexistent donor coronary disease? J Heart Lung Transplant. 1994;13:81.
Yeung AC, Davis S, Hauptman P et al. Incidence and progression of transplant coronary artery disease over one year: results of a multicenter trial using intravascular ultrasound. J Heart Lung Transplant. 1995;14:5215–20.
Russell M, Fujita M, Masek M et al. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation. 1993;56:762–4.
Lin H, Wilson J, Kendall T et al. Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts. J Heart Lung Transplant. 1994;13:824–33.
Mehra M, Ventura H, Stapleton D et al. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J. Heart Lung Transplant. 1995;14:5207–10.
Wiedermann JG, Wasserman HS, Weinberger JZ et al. Severe intimal thickening by intracoronary ultrasound predicts early death in cardiac transplant recipients. Circulation. 1994;90:1–93.
Johnson J, Kobashigawa J. Quantitative analysis of transplant coronary artery disease using intracoronary ultrasound. J Heart Lung Transplant. 1995;14:5198–201.
Waller B, Pinkerton C, Slack J. Intravascular ultrasound: a histological study of vessels during life. The new ‘gold standard’ for vascular imaging. Circulation. 1992;85:2305–10.
Doucette T, Carl P, Payne H et al. Validation of a doppler guidewirc for intravascular measurement of coronary flow velocity. Circulation. 1992;85:1879–1911.
McGinn A, White C, Wilson R. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. Circulation. 1990;81:1319–30.
Wolford T, Donohue T, Drury J et al. Extent of coronary myointimal proliferation and its relationship to resistance vessel function in the cardiac allograft. J Am Coll Cardiol. l995(Special issue): 158(abstract).
Wolford T, Donohue T, Bach R et al. Coronary flow reserve in angiographically normal coronary arteries varies with time post-transplantation. Eur Heart J. 1994;15:P3237.
Bitar JN, Young JB, Vardan S et al. Progressive deterioration of coronary reserve after heart transplant: a time-dependent observation. J Am Coll Cardiol. 1994 (Special issue):230A (abstract).
Ventura H, White C, Jain S et al. Assessment of intracoronary morphology in cardiac transplant recipients by angioscopy and intravascular ultrasound. Am J Cardiol. 1993;72:805–9.
Mills R, Billett J, Nichols W. Endothelial dysfunction early after heart transplantation. Assessment with intravascular ultrasound and doppler. Circulation. 1992;86:1171–4.
Fish R, Nabel E, Selwyn A et al. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988;81:21–31.
Treasure C, Vita J, Ganz P et al. Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients. Circulation. 1992;86:1156–64.
Yeung A, Anderson T, Meredith I et al. Endothelial dysfunction in the development and detection of transplant coronary artery disease. J Heart Lung Transplant. 1992;11:869–73.
Brown B, Maher V. Key references. Reversal of coronary heart disease by lipid lowering therapy. Observations and pathological mechanisms. Circulation. 1994;89:2928–33.
Superko H, Krauss R. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation. 1994;90:1056–69.
Anguita M, Alonso-Pulpon L. Arizon J et al. Comparison of the effectiveness of Iovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease. Am J Cardiol. 1994;74:776–9.
Ballantyne C, Radovancevic B, Farmer J et al. Hyperlipidemia after heart transplantation: report of a 6 year experience with treatment recommendations. J Am Coll Cardiol. 1992;19:1315–21.
Kobashigawa JA, UCLA Transplant Program. 1993 Unpublished data. Presented to the American Society of Transplant Physicians meeting, 1994, Chicago.
Kobashigawa JA, Katznelson S, Laks H et al. Effect of pravastatin on outcome after cardiac transplantation. N Engl J Med. 1995;333:621–7.
Eich D. Thompson J, Ko D et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant. 1991;10:45–9.
Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med. 1989;321:129–35.
Fuster V, Cohen M, Halperin J. Aspirin in the prevention of coronary disease. N Engl J Med. 1989;321:183–5.
Hoyt G, Gollin G, Billingham M et al. Effects of anti-platelet regimens in combination with cyclosporin on heart allograft vessel disease. J Heart Lung Transplant. 1984;4:54–6.
Muskett A, Burton N, Eichwald E et al. The effect of antiplatelet drugs on graft atherosclerosis in rat heterotopic cardiac allografts. Transplant Proc. 1987;19:74–6.
DeLorgeril M, Boissonnat P, Guidollet J et al. Clinical and laboratory risk factors for coronary heart disease in cardiac transplanted patients. 1989; XXI Course on Transplantation and Clinical Immunology. Amsterdam: Elsevier.
Grace A, Barradas M, Mikhailidis D et al. Cyclosporin A enhances platelet aggregation. Kidney Int. 1987;32:889–95.
Schroeder J, Gao S, Alderman E et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med. 1993;328:164–70.
Henry P. Calcium channel blockers and progression of coronary artery disease. Circulation. 1990;82:2251–3.
Paoletti R, Bernini F. A new generation of calcium antagonists and their role in atherosclerosis. Am J Cardiol. 1990;66:H28–31.
Waters D, Lesperance J, Francetich M et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation. 1990;82:1940–53.
Alivizatos P, Maxa J, Lucio S et al. The immunosuppressive qualities of calcium channel blockers. (Letter to editor) Transplantation. 1993;56:1604.
Sarris G, Mitchell R, Billingham M et al. Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thurac Cardiovasc Surg. 1989;97:841–55.
Israel D, Gorlin R. Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol. 1992;19:174–85.
Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992;85:950–6.
Young J. Fish oil and antioxidants after heart transplant: future strategies or eye of newt and wing of bat revisited? J Heart Lung Transplant. 1995;14:5250–4.
Gibbons G. Preventive treatment of graft coronary vascular discase: the potential role of vasodilator therapy. J Heart Lung Transplant. 1992;11:S22–7.
Powell JS, Clozel JP, Muller RK et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186–8.
Foegh ML, Zhao Y, Lou H et al. Estrogen and prevention of transplant atherosclerosis. J Heart Lung Transplant. (In press).
Foegh M. Angiopeptin: a treatment for accelerated myointimal hyperplasia? J Heart Lung Transplant. 1992;11:S28–31.
Wahlers T, Mugge A, Oppelt P et al. Preventive treatment of coronary vasculopathy in heart transplantation by inhibition of smooth muscle cell proliferation with angiopeptin. J Heart Lung Transplant. 1994;14:143–50.
Meiser BM, Mair H, Scheidt W et al. Significant reduction of graft vessel disease (GVD) after heart transplantation (HTx) by short-term angiopeptin treatment. Presented to the American Society of Transplant Physicians meeting, 1995, Chicago.
Gregory C, Huang X, Pratt R et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation. 1995;59:655–61.
Morris RE. Rapamycins: antifungal, antitumor, antiproliterative, and immunosuppressive macrolides. Transplant Rev. 1992;6:39.
Gregory C, Huie P, Billingham M et al. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Transplantation. 1993;55:1409–18.
Gao S, Schroeder J. Hunt S et al. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 1988;62:876–81.
Ensley R, Hunt S, Taylor D et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992;11:S142–58.
Christensen B, Meyer S, Iacarella C et al. Coronary angioplasty in heart transplant recipients: a quantitative angiographic long-term follow-up study. J Heart Lung Transplant. 1994;13:212–20.
Halle A. Wilson R, Massin R et al. Coronary angioplasty in cardiac transplant patients. Results of a multicenter study. Circulation. 1992;86:458–62.
Halle A, DiSciascio G, Massin F et al. Coronary angioplasty, atherectomy, and bypass surgery in cardiac transplant patients. J Am Coll Cardiol. 1995;26:120–8.
Jain S, Ventura H, Ramee S et al. Directional coronary atherectomy in heart transplant recipients. J Heart Lung Transplant. 1993;12:819–23.
Roberts M, Parameshwar J, Wallwork J et al. Coronary revascularization after cardiac transplantation. J Heart Lung Transplant. 1994;13:S48.
Heroux A, Winkel E, Johnson S et al. Cardiac allograft vasculopathy: angiographic features and implications for revascularization. Circulation. 1994;90:I–362 (abstract).
King S, Lembo N, Weintraub W et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044–50.
Kron I, Flanagan T. Blackbourne L et al. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg. 1989;210:348–54.
Cooley DA, Frazier OH, Kadipasaoglu KA et al. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Texas Heart Inst J. 1994;21:220–4.
Frazier OH, Cooley DA, Kadipasaoglu KA et al. Transmyocardial laser revascularization: initial clinical results. Circulation. 1994;90:I–640 (abstract).
March RJ. Cardiac allograft vasculopathy: the potential role for transmyocardial laser revascularization. J Heart Lung Transplant. 1995;14:5242–9.
Ortu P, LaMuraglia G, Roberts G et al. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation. 1992;85:1189–96.
Dartsch P, Ischinger T, Betz E. Response of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photo radiation: implication for photodynamic therapy of vascular stenosis. J Am Coll Cardiol. 1990:15:1545–50.
Fyfe A, Ardehali A, Laks H et al. Biologic modification of the immune response in mouse cardiac isografts using gene transfer. J Heart Lung Transplant. 1995;14:5165–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Miller, L.W., Donahue, T., Wolford, T., Drury, J. (1996). Diagnosis and Management of Cardiac Allograft Vasculopathy (Chronic Rejection). In: Cooper, D.K.C., Miller, L.W., Patterson, G.A. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-34287-0_35
Download citation
DOI: https://doi.org/10.1007/978-0-585-34287-0_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-8898-2
Online ISBN: 978-0-585-34287-0
eBook Packages: Springer Book Archive